Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- CheckyesterdayChange DetectedThe page history now displays Revision: v3.6.5, replacing the previous v3.6.4. This reflects a software version update for the ClinicalTrials.gov interface rather than a change to study information.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history now shows a new revision, v3.6.4, as the current version, replacing the previous v3.6.3 in the history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history now shows the latest revision tag as v3.6.3, replacing the previous v3.6.2.SummaryDifference0.1%

- Check44 days agoChange DetectedThe history now shows a new revision entry, v3.6.2, replacing the prior v3.6.0, indicating a software update to the page's versioning of the study record.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded 'No longer looking for participants' and 'Revision: v3.6.0' to the record history. Removed the previous revision tag 'Revision: v3.5.5'.SummaryDifference0.3%

- Check66 days agoChange DetectedA new latest revision label (v3.5.5) appears in the page history, updating the version sequence from the previous revision (v3.5.4).SummaryDifference0.1%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.